Health Affairs Scholar 2026
TRIPS, Pharmaceutical Patents, and Generic Competition in India (replication)
This package is used to reproduce research on health, IP, or related policy using Indian data.
Margaret K. Kyle; Bhaven N. Sampat; Kenneth C. Shadlen · 2026 · Harvard Dataverse
Harvard Dataverse · Health Affairs Scholar
India
Pharmaceutical markets (article period)
Article package (2026)
What this is best for
Patent and generic-competition replication with mixed public and restricted market data
Main limitations
IQVIA Ark and MIDAS inputs restricted by commercial agreement — mixed package
Quick answers
Short research-facing answers derived from this catalog record.
- What is Kyle et al. 2026 used for?
- Patent and generic-competition replication with mixed public and restricted market data
- How do you access Kyle et al. 2026 data?
- Kyle et al. 2026 is labeled “Open download” on this guide. Open the access portal or documentation links on the record for the current host process—do not assume open download if registration or a DUA is required.
- What geography and time does Kyle et al. 2026 cover?
- Geography: India. Time coverage: Pharmaceutical markets (article period).
- What are the main limitations of Kyle et al. 2026?
- IQVIA Ark and MIDAS inputs restricted by commercial agreement — mixed package
Guides for using this data
Official portals, user guides, codebooks, and tutorials for access and analysis.
Variables4
Live-fetched dataverse.harvard.edu (2026-07-09). Representative fields for the page table — verify the full dictionary on the official site.
Sourced from live host documentation
Pairs well with
Many Indian data problems need survey + administrative combinations.